Page last updated: 2024-09-05

sb 203580 and aldosterone

sb 203580 has been researched along with aldosterone in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(aldosterone)
Trials
(aldosterone)
Recent Studies (post-2010) (aldosterone)
3,48941,13725,3331,5174,169

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)aldosterone (IC50)
Mineralocorticoid receptor Homo sapiens (human)0.0048
Mineralocorticoid receptorRattus norvegicus (Norway rat)0.043

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, YP; Luo, Y; Rui, HL1

Other Studies

1 other study(ies) available for sb 203580 and aldosterone

ArticleYear
[The role of MAPK/ERK1/2 signaling pathway in aldosterone stimulated transforming growth factor-beta1 synthesis in renal tubular epithelial cells].
    Zhonghua yi xue za zhi, 2006, Nov-28, Volume: 86, Issue:44

    Topics: Aldosterone; Anthracenes; Blotting, Western; Butadienes; Cells, Cultured; Dose-Response Relationship, Drug; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Humans; Imidazoles; Kidney Tubules, Proximal; Mifepristone; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitriles; Phosphorylation; Pyridines; Signal Transduction; Time Factors; Transforming Growth Factor beta1

2006